1. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. (12th March 2018) Authors: Castillo, Jorge J.; Guerrero‐Garcia, Thomas; Baldini, Francesco; Tchernonog, Emmanuelle; Cartron, Guillaume; Ninkovic, Slavisa; Cwynarski, Kate; Dierickx, Daan; Tousseyn, Thomas; Lansigan, Frederick; Linnik, Yevgeny; Mogollon, Renzo; Navarro, Jose‐Tomás; Olszewski, Adam J.; Reagan, John L.; Fedel... Journal: British journal of haematology Issue: Volume 184:Number 4(2019) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗